Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle‐Branch Block After Septal Myectomy
* Correspondence to: Christopher Madias, MD, Division of Cardiology, Cardiovascular Center, Tufts Medical Center, 800 Washington St., Boston, MA 02111. Email: The subcutaneous implantable cardioverter defibrillator (SICD) is effective for sudden cardiac death prevention in patients with hypertrophic cardiomyopathy (HCM). 1 SICDs can be used in eligible patients without pacing indications to avoid the potential complications associated with intravascular lead placement. Preimplant ECG screening to